THE Philippine Food and Drug Administration (FDA) recently announced the approval of oral medicine Olaparib for the treatment of various types of cancers such as patients with advanced ovarian, breast, prostate and pancreatic cancer.
AstraZeneca Philippines brings this drug to the country, celebrating this huge milestone for Filipinos with a stronger push to promote early doctor consultation to assess cancer risk and get treated.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.